Učitavanje...
Dabrafenib and Trametinib for BRAF-Mutated Conjunctival Melanoma
BACKGROUND: Conjunctival melanoma is a potentially lethal malignancy of the ocular surface. There have been no therapeutic advancements made in the past several decades despite increasing prevalence of the disease. METHODS: The authors report the case of a 52-year-old Caucasian male with unresectabl...
Spremljeno u:
| Izdano u: | Ocul Oncol Pathol |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
S. Karger AG
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6984155/ https://ncbi.nlm.nih.gov/pubmed/32002403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000497473 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|